Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice

Jack C. Reidling, Aroa Relaño-Ginés, Sandra M. Holley, Joseph Ochaba, Cindy Moore, Brian Fury, Alice Lau, Andrew H. Tran, Sylvia Yeung, Delaram Salamati, Chunni Zhu, Asa Hatami, Carlos Cepeda, Joshua A. Barry, Talia Kamdjou, Alvin King, Dane Coleal-Bergum, Nicholas R. Franich, Frank M. LaFerla, Joan S. SteffanMathew Blurton-Jones, Charles K. Meshul, Gerhard Bauer, Michael S. Levine, Marie Francoise Chesselet, Leslie M. Thompson

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Huntington's disease (HD) is an inherited neurodegenerative disorder with no disease-modifying treatment. Expansion of the glutamine-encoding repeat in the Huntingtin (HTT) gene causes broad effects that are a challenge for single treatment strategies. Strategies based on human stem cells offer a promising option. We evaluated efficacy of transplanting a good manufacturing practice (GMP)-grade human embryonic stem cell-derived neural stem cell (hNSC) line into striatum of HD modeled mice. In HD fragment model R6/2 mice, transplants improve motor deficits, rescue synaptic alterations, and are contacted by nerve terminals from mouse cells. Furthermore, implanted hNSCs are electrophysiologically active. hNSCs also improved motor and late-stage cognitive impairment in a second HD model, Q140 knockin mice. Disease-modifying activity is suggested by the reduction of aberrant accumulation of mutant HTT protein and expression of brain-derived neurotrophic factor (BDNF) in both models. These findings hold promise for future development of stem cell-based therapies. Human GMP-grade neural stem cell transplantation rescues behavioral deficits and electrophysiological alterations in Huntington's disease mice, and rescue is associated with reduced accumulation of mutant Huntingtin protein.

Original languageEnglish (US)
Pages (from-to)58-72
Number of pages15
JournalStem Cell Reports
Volume10
Issue number1
DOIs
StatePublished - Jan 1 2018

Fingerprint

Neural Stem Cells
Huntington Disease
Stem Cell Transplantation
Stem cells
Mutant Proteins
Stem Cells
Brain-Derived Neurotrophic Factor
Cell- and Tissue-Based Therapy
Glutamine
Neurodegenerative Diseases
Transplants
Cell Line
Proteins
Genes
Therapeutics

Keywords

  • embryonic stem cells
  • Huntington's disease
  • neural stem cell
  • Q140 mice
  • R6/2 mice
  • transplantation

ASJC Scopus subject areas

  • Biochemistry
  • Genetics
  • Developmental Biology
  • Cell Biology

Cite this

Reidling, J. C., Relaño-Ginés, A., Holley, S. M., Ochaba, J., Moore, C., Fury, B., ... Thompson, L. M. (2018). Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. Stem Cell Reports, 10(1), 58-72. https://doi.org/10.1016/j.stemcr.2017.11.005

Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. / Reidling, Jack C.; Relaño-Ginés, Aroa; Holley, Sandra M.; Ochaba, Joseph; Moore, Cindy; Fury, Brian; Lau, Alice; Tran, Andrew H.; Yeung, Sylvia; Salamati, Delaram; Zhu, Chunni; Hatami, Asa; Cepeda, Carlos; Barry, Joshua A.; Kamdjou, Talia; King, Alvin; Coleal-Bergum, Dane; Franich, Nicholas R.; LaFerla, Frank M.; Steffan, Joan S.; Blurton-Jones, Mathew; Meshul, Charles K.; Bauer, Gerhard; Levine, Michael S.; Chesselet, Marie Francoise; Thompson, Leslie M.

In: Stem Cell Reports, Vol. 10, No. 1, 01.01.2018, p. 58-72.

Research output: Contribution to journalArticle

Reidling, JC, Relaño-Ginés, A, Holley, SM, Ochaba, J, Moore, C, Fury, B, Lau, A, Tran, AH, Yeung, S, Salamati, D, Zhu, C, Hatami, A, Cepeda, C, Barry, JA, Kamdjou, T, King, A, Coleal-Bergum, D, Franich, NR, LaFerla, FM, Steffan, JS, Blurton-Jones, M, Meshul, CK, Bauer, G, Levine, MS, Chesselet, MF & Thompson, LM 2018, 'Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice', Stem Cell Reports, vol. 10, no. 1, pp. 58-72. https://doi.org/10.1016/j.stemcr.2017.11.005
Reidling, Jack C. ; Relaño-Ginés, Aroa ; Holley, Sandra M. ; Ochaba, Joseph ; Moore, Cindy ; Fury, Brian ; Lau, Alice ; Tran, Andrew H. ; Yeung, Sylvia ; Salamati, Delaram ; Zhu, Chunni ; Hatami, Asa ; Cepeda, Carlos ; Barry, Joshua A. ; Kamdjou, Talia ; King, Alvin ; Coleal-Bergum, Dane ; Franich, Nicholas R. ; LaFerla, Frank M. ; Steffan, Joan S. ; Blurton-Jones, Mathew ; Meshul, Charles K. ; Bauer, Gerhard ; Levine, Michael S. ; Chesselet, Marie Francoise ; Thompson, Leslie M. / Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice. In: Stem Cell Reports. 2018 ; Vol. 10, No. 1. pp. 58-72.
@article{f6d76885123044aca969b3b4405f1b66,
title = "Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice",
abstract = "Huntington's disease (HD) is an inherited neurodegenerative disorder with no disease-modifying treatment. Expansion of the glutamine-encoding repeat in the Huntingtin (HTT) gene causes broad effects that are a challenge for single treatment strategies. Strategies based on human stem cells offer a promising option. We evaluated efficacy of transplanting a good manufacturing practice (GMP)-grade human embryonic stem cell-derived neural stem cell (hNSC) line into striatum of HD modeled mice. In HD fragment model R6/2 mice, transplants improve motor deficits, rescue synaptic alterations, and are contacted by nerve terminals from mouse cells. Furthermore, implanted hNSCs are electrophysiologically active. hNSCs also improved motor and late-stage cognitive impairment in a second HD model, Q140 knockin mice. Disease-modifying activity is suggested by the reduction of aberrant accumulation of mutant HTT protein and expression of brain-derived neurotrophic factor (BDNF) in both models. These findings hold promise for future development of stem cell-based therapies. Human GMP-grade neural stem cell transplantation rescues behavioral deficits and electrophysiological alterations in Huntington's disease mice, and rescue is associated with reduced accumulation of mutant Huntingtin protein.",
keywords = "embryonic stem cells, Huntington's disease, neural stem cell, Q140 mice, R6/2 mice, transplantation",
author = "Reidling, {Jack C.} and Aroa Rela{\~n}o-Gin{\'e}s and Holley, {Sandra M.} and Joseph Ochaba and Cindy Moore and Brian Fury and Alice Lau and Tran, {Andrew H.} and Sylvia Yeung and Delaram Salamati and Chunni Zhu and Asa Hatami and Carlos Cepeda and Barry, {Joshua A.} and Talia Kamdjou and Alvin King and Dane Coleal-Bergum and Franich, {Nicholas R.} and LaFerla, {Frank M.} and Steffan, {Joan S.} and Mathew Blurton-Jones and Meshul, {Charles K.} and Gerhard Bauer and Levine, {Michael S.} and Chesselet, {Marie Francoise} and Thompson, {Leslie M.}",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.stemcr.2017.11.005",
language = "English (US)",
volume = "10",
pages = "58--72",
journal = "Stem Cell Reports",
issn = "2213-6711",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice

AU - Reidling, Jack C.

AU - Relaño-Ginés, Aroa

AU - Holley, Sandra M.

AU - Ochaba, Joseph

AU - Moore, Cindy

AU - Fury, Brian

AU - Lau, Alice

AU - Tran, Andrew H.

AU - Yeung, Sylvia

AU - Salamati, Delaram

AU - Zhu, Chunni

AU - Hatami, Asa

AU - Cepeda, Carlos

AU - Barry, Joshua A.

AU - Kamdjou, Talia

AU - King, Alvin

AU - Coleal-Bergum, Dane

AU - Franich, Nicholas R.

AU - LaFerla, Frank M.

AU - Steffan, Joan S.

AU - Blurton-Jones, Mathew

AU - Meshul, Charles K.

AU - Bauer, Gerhard

AU - Levine, Michael S.

AU - Chesselet, Marie Francoise

AU - Thompson, Leslie M.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Huntington's disease (HD) is an inherited neurodegenerative disorder with no disease-modifying treatment. Expansion of the glutamine-encoding repeat in the Huntingtin (HTT) gene causes broad effects that are a challenge for single treatment strategies. Strategies based on human stem cells offer a promising option. We evaluated efficacy of transplanting a good manufacturing practice (GMP)-grade human embryonic stem cell-derived neural stem cell (hNSC) line into striatum of HD modeled mice. In HD fragment model R6/2 mice, transplants improve motor deficits, rescue synaptic alterations, and are contacted by nerve terminals from mouse cells. Furthermore, implanted hNSCs are electrophysiologically active. hNSCs also improved motor and late-stage cognitive impairment in a second HD model, Q140 knockin mice. Disease-modifying activity is suggested by the reduction of aberrant accumulation of mutant HTT protein and expression of brain-derived neurotrophic factor (BDNF) in both models. These findings hold promise for future development of stem cell-based therapies. Human GMP-grade neural stem cell transplantation rescues behavioral deficits and electrophysiological alterations in Huntington's disease mice, and rescue is associated with reduced accumulation of mutant Huntingtin protein.

AB - Huntington's disease (HD) is an inherited neurodegenerative disorder with no disease-modifying treatment. Expansion of the glutamine-encoding repeat in the Huntingtin (HTT) gene causes broad effects that are a challenge for single treatment strategies. Strategies based on human stem cells offer a promising option. We evaluated efficacy of transplanting a good manufacturing practice (GMP)-grade human embryonic stem cell-derived neural stem cell (hNSC) line into striatum of HD modeled mice. In HD fragment model R6/2 mice, transplants improve motor deficits, rescue synaptic alterations, and are contacted by nerve terminals from mouse cells. Furthermore, implanted hNSCs are electrophysiologically active. hNSCs also improved motor and late-stage cognitive impairment in a second HD model, Q140 knockin mice. Disease-modifying activity is suggested by the reduction of aberrant accumulation of mutant HTT protein and expression of brain-derived neurotrophic factor (BDNF) in both models. These findings hold promise for future development of stem cell-based therapies. Human GMP-grade neural stem cell transplantation rescues behavioral deficits and electrophysiological alterations in Huntington's disease mice, and rescue is associated with reduced accumulation of mutant Huntingtin protein.

KW - embryonic stem cells

KW - Huntington's disease

KW - neural stem cell

KW - Q140 mice

KW - R6/2 mice

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=85042742430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042742430&partnerID=8YFLogxK

U2 - 10.1016/j.stemcr.2017.11.005

DO - 10.1016/j.stemcr.2017.11.005

M3 - Article

C2 - 29233555

AN - SCOPUS:85042742430

VL - 10

SP - 58

EP - 72

JO - Stem Cell Reports

JF - Stem Cell Reports

SN - 2213-6711

IS - 1

ER -